Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BLK vs GSK✓SelectedUSD · GSKBLK vs GSK performance historyLatest closeAs of-2.86%11/19
Stock and ETF performance explorer

BLK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+13,557.4%
GSK return
+215.9%
Excess return
+13,341.5%
Maximum drawdown
-60.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.9%-1.6%-1.3%-2.2%
7D-6.6%-4.7%-1.9%-4.7%
30D+0.6%-4.7%+5.3%+2.6%
3M-1.5%-8.8%+7.3%+2.2%
6M+10.8%-4.6%+15.4%+12.3%
YTD+7.9%+1.0%+6.9%+5.7%
1Y+14.3%+6.9%+7.5%+9.3%
3Y+69.4%+52.5%+16.9%+32.9%
5Y+40.1%+40.3%-0.1%+12.1%
10Y+289.6%+99.0%+190.7%+161.8%
All+13,557.4%+215.9%+13,341.5%+7,456.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling